Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.96T | 1.54T | 1.63T | 1.81T | 1.49T |
Gross Profit | 166.65B | 148.15B | 176.77B | 208.80B | 172.35B |
EBITDA | 106.02B | 102.24B | 96.16B | 120.80B | 92.91B |
Net Income | 34.08B | 29.79B | 20.33B | 45.02B | 24.41B |
Balance Sheet | |||||
Total Assets | 2.38T | 2.17T | 1.89T | 2.13T | 2.04T |
Cash, Cash Equivalents and Short-Term Investments | 91.61B | 134.92B | 142.13B | 159.22B | 153.09B |
Total Debt | 593.10B | 603.16B | 533.56B | 608.71B | 629.48B |
Total Liabilities | 1.68T | 1.48T | 1.26T | 1.47T | 1.42T |
Stockholders Equity | 677.25B | 653.64B | 593.32B | 584.82B | 545.23B |
Cash Flow | |||||
Free Cash Flow | 2.81B | -31.60B | -31.55B | -71.27B | -285.00M |
Operating Cash Flow | 58.89B | 51.35B | 45.16B | 6.89B | 78.44B |
Investing Cash Flow | -79.38B | -103.00B | -43.98B | -3.21B | -101.76B |
Financing Cash Flow | -13.21B | 32.92B | 3.47B | -5.05B | 41.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | €96.66B | 5.12 | 15.20% | 2.29% | 7.28% | 22.26% | |
80 Outperform | €133.70B | 15.94 | 5.92% | 2.72% | 12.71% | -1.52% | |
77 Outperform | $106.83B | 38.46 | 4.87% | 1.18% | 7.37% | -47.09% | |
71 Outperform | $332.76B | 36.68 | 1.33% | 3.97% | 11.12% | -80.21% | |
70 Outperform | ¥182.19B | 11.36 | 5.69% | 3.07% | 2.62% | -12.22% | |
68 Neutral | $301.98B | 13.90 | 5.76% | 2.93% | -9.15% | -31.58% | |
53 Neutral | $1.03T | 46.94 | 1.31% | 2.79% | 5.12% | -63.31% |